Medpace Holdings Inc (NASDAQ:MEDP) reported first-quarter financial results after market close on Monday. Here’s a look at the key metrics from the quarter.
Total revenue was up 9.3% on a year-over-year basis. New business awards totaled $500 million in the quarter, down 18.8% year-over-year. The company ended the period with a backlog of approximately $2.85 billion, down 2.1% year-over-year.
Medpace generated $125.8 million in cash flow from operations during the quarter. The company said it repurchased approximately 1.19 million shares for $389.8 million in the first quarter. Medpace’s board also authorized a $1 billion increase to the company’s buyback, bringing the total authorization up to approximately $1.34 billion.
The company ended the quarter with $441.4 million in cash and cash equivalents.
Outlook: Medpace expects full-year 2025 revenue to be between $2.14 billion and $2.24 billion versus estimates of $2.15 billion. The company anticipates full-year earnings of $12.26 to $13.04 per share versus estimates of $12.27 per share.
Medpace executives will further discuss the quarter on a call with investors and analysts Tuesday morning at 9 a.m. ET.
MEDP Price Action: Medpace shares were down 9.34% after-hours, trading at $262 at the time of publication Monday, according to Benzinga Pro.
Check This Out: • Calix Stock Jumps On Strong Q1 Earnings, $100 Million Buyback Increase
Photo: mariakray/Shutterstock.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.